Paritaprevir, CAS [[1216941-48-8]]

Produktübersicht

• Artikelname: Paritaprevir, CAS [[1216941-48-8]]
• Artikelnummer: MCE-HY-12594
• Hersteller Artikelnummer: HY-12594
• Alternativnummer: MCE-HY-12594-10MG,MCE-HY-12594-5MG,MCE-HY-12594-100MG,MCE-HY-12594-50MG,MCE-HY-12594-25MG,MCE-HY-12594-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ABT-450, Veruprevir

Produktbeschreibung

Paritaprevir (ABT-450) is a potent, orally active and antiviral non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. Paritaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.31 µM. Paritaprevir is metabolized primarily by cytochrome P450 (CYP) 3A. The plasma concentration and half-life of Paritaprevir can be enhanced by Ritonavir (a CYP450 inhibitor)[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 765.88
• Reinheit: 99.87
• CAS Nummer: [1216941-48-8]
• Formel: C40H43N7O7S
• Target-Kategorie: HCV,HCV Protease,SARS-CoV

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound